Author(s): Sarfaraz Ahmad, Ambreen Shoaib, Md. Sajid Ali, Md. Sarfaraz Alam, Nawazish Alam, Maksood Ali, Md. Ali Mujtaba, Ayaz Ahmad, Md. Salahuddin Ansari, Mohammad Daud Ali

Email(s): dali.niper@gmail.com

DOI: 10.52711/0974-360X.2021.00408   

Address: Sarfaraz Ahmad1, Ambreen Shoaib1, Md. Sajid Ali3, Md. Sarfaraz Alam3, Nawazish Alam1, Maksood Ali4, Md. Ali Mujtaba5, Ayaz Ahmad2, Md. Salahuddin Ansari6, Mohammad Daud Ali2*
1Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
2Department of Pharmacy, Mohammed Al-Mana College for Medical Sciences, Abdulrazaq Bin Hammam Street, As Safa, Dammam, Saudi Arabia.
3Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
4Department of Pharmacognosy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
5Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Kingdom of Saudi Arabia.
6College of Pharmacy, Al-Dawadmi, Shaqra University, Saudi Arabia.
*Corresponding Author

Published In:   Volume - 14,      Issue - 4,     Year - 2021


ABSTRACT:
The novel human coronavirus disease (COVID-19) is the major pandemic throughout the globe and its occurrence is due to the presence of severe acute respiratory syndrome coronavirus (SARS-CoV2). That began from Wuhan, Hubei province of China in late 2019 and afterward drastically spread worldwide. It effects around 213 countries and territories around the globe and have reported a total of 8,128,490 confirmed cases of COVID-19. As an unprecedented global pandemic it sweeps the planet and affects each and every human being either physically, mentally or economically. The most common symptoms of COVID-19 are pyrexia, tiredness, and dry cough but in some cases it is asymptomatic. It can be diagnosed by a health care provider based on symptoms and confirmed through laboratory tests. Till date there is not even a single drug or vaccine that can be used for the effective treatment for this disease. The international community is to introduce a global synchronized strength to prevent the outbreak that needs a strong public health response, high level political commitment and sufficient funding. The aim of this review article is to summarise the recent state of awareness, epidemiology and social impact on surrounding due to outbreak of COVID-19 pandemic.


Cite this article:
Sarfaraz Ahmad, Ambreen Shoaib, Md. Sajid Ali, Md. Sarfaraz Alam, Nawazish Alam, Maksood Ali, Md. Ali Mujtaba, Ayaz Ahmad, Md. Salahuddin Ansari, Mohammad Daud Ali. Epidemiology, Risk, Myths, Pharmacotherapeutic Management and Socio- economic Burden due to Novel COVID-19: A Recent Update. Research Journal of Pharmacy and Technology. 2021; 14(4):2308-5. doi: 10.52711/0974-360X.2021.00408

Cite(Electronic):
Sarfaraz Ahmad, Ambreen Shoaib, Md. Sajid Ali, Md. Sarfaraz Alam, Nawazish Alam, Maksood Ali, Md. Ali Mujtaba, Ayaz Ahmad, Md. Salahuddin Ansari, Mohammad Daud Ali. Epidemiology, Risk, Myths, Pharmacotherapeutic Management and Socio- economic Burden due to Novel COVID-19: A Recent Update. Research Journal of Pharmacy and Technology. 2021; 14(4):2308-5. doi: 10.52711/0974-360X.2021.00408   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-4-84


REFERENCES:
1. Mackenzie, John S, and David W Smith. “COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't.” Microbiology Australia, MA20013. 2020.
2. Singhal, Tanu. “A Review of Coronavirus Disease-2019 (COVID-19).” Indian journal of pediatrics vol. 87,4 (2020): 281- 286.
3. Nabeel Kashan Syed, Omer Nasir, Nawazish Alam, Mohamed Sayed-Ahmed, Sarfaraz Ahmad, Zia Nadeem, Santhosh Mathews, Anil Babu. Zika Virus: A Global Pandemic of Colossal Proportions. Research J. Pharm. and Tech 2016; 9(8): 1245-1248.
4. Praba. B, Deepa. G, Chandrasekaran. V.M. Spreading Rate of Virus on Energy of Dominating Intuitionistic Fuzzy Graph. Research J. Pharm. and Tech. 2017; 10(3): 882-890.
5. Shiv Kumar Kushawaha, Neelam Raj, Manish Sinha, Puneet Kumar, Mahendra Singh Ashawat. Nipah Virus and its Outbreaks in Tropical Areas. Research J. Pharm. and Tech. 2020; 13(1): 491-497.
6. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009 Jun;7(6): 439-50.
7. https://www.va.gov/opa/docs/VHA_COVID_19_03232020_vF_1.pdf.
8. Chan JF, To KK, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013;21(10): 544-55.
9. https://www.cdc.gov/coronavirus/types.html
10. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020 Apr;92(4): 418-423.
11. Centers for Disease Control and Prevention, Human Coronavirus Types https://www.cdc.gov/coronavirus/types.html (Last assess on 20th March 2020).
12. Thant Z., Tengku M. A., Azmi H., Norizhar K. Dengue Virus Infections: Global Scenario, Classification, and Clinical Manifestations– A Review. Research J. Pharm. and Tech. 2016;9(1): 83-90.
13. Fadyia Mahdi Muslim Alameedy. Diagnosis of Human Papilloma virus in Colorectal Cancer and Inhibition by Gamma Radiation. Research J. Pharm. and Tech. 2019; 12(5): 2343-2345.
14. https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations.
15. https://www.sciencemag.org/news/2020/01/novel-human-virus-pneumonia-cases-linked-seafood-market-china-stir-concern.
16. Guo, Y., Cao, Q., Hong, Z. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med Res, 2020;7:11.
17. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951.
18. https://www.eurekalert.org/pub_releases/2020-03/f-ccs031020.php.
19. Zhou, P.; Yang, X.-L.; Wang, X.-G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.-R.; Zhu, Y.; Li, B.; Huang, C.-L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273.
20. Rothe, C.; Schunk, M.; Sothmann, P.; Bretzel, G.; Froeschl, G.; Wallrauch, C.; Zimmer, T.; Thiel, V.; Janke, C.; Guggemos, W. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 2020, 382, 970–971.
21. Li, J.-Y.; You, Z.; Wang, Q.; Zhou, Z.-J.; Qiu, Y.; Luo, R.; Ge, X.-Y. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microb. Infect. 2020, 22, 80–85.
22. Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S.C. and Di Napoli, R., 2020. Features, evaluation and treatment coronavirus (COVID-19). In Statpearls [internet]. Stat Pearls Publishing.
23. Sanket. S. Patil, Shubhangi. S. Mali, Rushikesh. R. Patil, P. S. Kore. Zika Virus: Infection, Virus, Development and Process of Vaccines. Research J. Pharm. and Tech 2018; 11(11): 5159-5162.
24. Coronavirus disease 2019 (COVID-19) https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19(Last assess on 20th March 2020).
25. Daga MK, Kumar N, Aarthi J, Mawari G, Garg S, Rohatgi I. From SARS-CoV to Coronavirus Disease 2019 (COVID-19)-A Brief Review. Journal of Advanced Research in Medicine (E-ISSN: 2349-7181 & P-ISSN: 2394-7047). 2019; 6(4):1-9.
26. Hanson KE, Azar MM, Banerjee R, Chou A, Colgrove RC, Ginocchio CC, Hayden MK, Holodiny M, Jain S, Koo S, Levy J. Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA’s Diagnostics Committee. Clinical Infectious Diseases. 2020.
27. D'Adamo H, Yoshikawa T, Ouslander JG. Coronavirus disease 2019 in geriatrics and long‐term care: the ABCDs of COVID‐19. Journal of the American Geriatrics Society. 2020;68(5):912-7.
28. Killerby ME, Biggs HM, Haynes A, Dahl RM, et al. Human coronavirus circulation in the United States 2014 – 2017external icon. Journal of Clinical Virology. 2018; 101: 52-6.
29. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020 Mar 17;323(11): 1061-9.
30. Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID‐19. American Journal of Hematology. 2020.
31. "WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020". World Health Organization. 2020. 
32. World Health Organization. WHO Disease outbreak news: Novel Coronavirus – Republic of Korea (ex-China). January 21, 2020. https://www.who.int/csr/don/21-january-2020-novel-coronavirus-republic-of-korea-ex-china/en/ (Accessed on January 21, 2020).
33. Perlman, S. (February 2020). "Another Decade, another Coronavirus". The New England Journal of Medicine. 382 (8): 760-762.
34. Wong, M. C.; Cregeen, S. J.; Ajami, N. J.; Petrosino, J. F. "Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019" ; 2020.
35. "Coronavirus COVID-19 Global Cases". Johns Hopkins University. Retrieved 16 June 2020.
36. COVID-19 coronavirus pandemic https://www.worldometers.info/coronavirus/ (Last assess on 16 June 2020).
37. Walker, James (14 March 2020). "China Traces Coronavirus to First Confirmed Case, Nearly Identifying 'Patient Zero'". Newsweek. (Last assess on 20th March 2020).
38. Situation update worldwide, as of 23 March 2020 https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases (Last assess on 24th March 2020).
39. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200615-covid-19-sitrep-147.pdf?sfvrsn=2497a605_4(Last assess on 16th June 2020).
40. Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance(Last assess on 20th March 2020).
41. Nasal and pharyngeal swab specimens or blood samples tested positive for 2019-nCoV nucleic acid using real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assay;
42. Genetic sequencing of respiratory tract or blood samples is highly homologous with 2019-nCoV.
43. World Health Organization. Rational use of personal protective equipment for coronavirus disease (COVID-19): interim guidance, 27 February 2020. World Health Organization; 2020.
44. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries and Therapeutics. 2020;14(1): 58-60.
45. Wendy E. Parmet, J.D., and Michael S. Sinha, M.D., J.D., M.P.H. Covid-19 — The Law and Limits of Quarantine. DOI: 10.1056/NEJMp2004211.
46. COVID-19: Understanding Quarantine, Isolation and Social Distancing in a Pandemic.https://health.clevelandclinic.org/covid-19-understanding-quarantine-isolation-and-social-distancing-in-a-pandemic/(Last assess on 20th March 2020).
47. Atkeson A. What will be the economic impact of COVID-19 in the US? Rough estimates of disease scenarios. National Bureau of Economic Research; 2020 Mar 19.
48. Battegay Manuela, KuehlRicharda, Tschudin-Sutter Saraha, Hirsch Hans H, Widmer Andreas F.a, Neher Richard.2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate – a word of caution. Swiss Med Wkly. 2020;150: w20203.
49. Shi Zhao, QianyinLinc, JinjunRand, SalihS.Musae, GuangpuYang, Weiming Wang, Yijun Lou, DaozhouGao, Lin Yang, Daihai He, Maggie H.WangabInternational Journal of Infectious Diseases.Volume 92, March 2020, Pages 214-217.
50. Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, XiaoyingGu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, ShengjinTu, Yi Zhang, Hua Chen, Bin Cao.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. S0140-6736(20)30566-3.
51. Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests https://www.fda.gov/medical-devices/virtual-town-hall-series-immediately-effect-guidance-coronavirus-covid-19-diagnostic-tests-03252020(Last assess on 20thMarch 2020).
52. Kaiser's COVID-19 Chief Shares Surge Strategies https://www.medscape.com/viewarticle/927283(Last assess on 20thMarch 2020).
53. Mian, A., Khan, S. Coronavirus: the spread of misinformation. BMC Med 18, 89 (2020).
54. Coronavirus disease (COVID-19) advice for the public: Myth busters https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters)(Last assess on 20thMarch 2020).
55. Coronavirus health myths, fact checked (https://www.cnet.com/news/coronavirus-health-myths-fact-checked/)

Recomonded Articles:

Author(s): Rakhi Mehra, Renu Makhija, Neera Vyas

DOI: Not Available         Access: Open Access Read More

Author(s): S. R Suseem, Dhanish Joseph

DOI: 10.5958/0974-360X.2019.00067.2         Access: Open Access Read More

Author(s): Vaseeha Banu T.S., Sandhya K.V., K.N. Jayaveera

DOI: Not Available         Access: Open Access Read More

Author(s): Senthilkumar S., Ajithkumar, Sangeetha. S

DOI: 10.5958/0974-360X.2019.00837.0         Access: Open Access Read More

Author(s): Basil K Varghese, Geraldine Bessie Amali D, Uma Devi K S

DOI: 10.5958/0974-360X.2019.00114.8         Access: Open Access Read More

Author(s): Sahil Choudhari, Vishnu Priya .V, R. Gayathri

DOI: 10.5958/0974-360X.2016.00362.0         Access: Open Access Read More

Author(s): M U Uhumwangho, K Latha, S A Sunil, M V Srikanth, K V Ramana Murthy

DOI: Not Available         Access: Open Access Read More

Author(s): Sri Roja. I, E. Shanmugapriya, P. Shanmugasundaram

DOI: 10.5958/0974-360X.2017.00389.4         Access: Open Access Read More

Author(s): Vijayalakshmi B, Dhanraj Ganapathy

DOI: 10.5958/0974-360X.2016.00422.4         Access: Open Access Read More

Author(s): Sai Chaitanya Raj. B, Gheena Sukumaran

DOI: 10.5958/0974-360X.2015.00216.4         Access: Open Access Read More

Author(s): Renuka J. Das, N J Duragkar, Milind J. Umekar, Parimal Katolkar

DOI: 10.5958/0974-360X.2017.00585.6         Access: Open Access Read More

Author(s): Rasana Patil, Tina Makhija, H. P. Suryawanshi, S.P. Pawar

DOI: Not Available         Access: Open Access Read More

Author(s): A. Shreya Svitlana

DOI: 10.5958/0974-360X.2016.00243.2         Access: Open Access Read More

Author(s): Prativa Biswasroy, Sthitapragnya Panda, Debajyoti Das, Durga Madhab Kar, Goutam Ghosh

DOI: 10.5958/0974-360X.2020.00090.6         Access: Open Access Read More

Author(s): Vidya V Gawande, AV Chandewar

DOI: Not Available         Access: Open Access Read More

Author(s): S. Gupta, A. M. Shaikh, B. Mohanty, P. Chaudhari, P. B. Parab, K. G. Apte

DOI: 10.5958/0974-360X.2020.00325.X         Access: Open Access Read More

Author(s): Sam Mirfendereski, Arash Shabani, Ayoob Rostamzadeh, Daryoush Fatehi

DOI: 10.5958/0974-360X.2017.00312.2         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags